medigraphic.com
ISSN 0210-5187 (Electronic)

2008, Number 3

<< Back Next >>

Med Cutan Iber Lat Am 2008; 36 (3)

Community-adquired methicilin-resistant Staphylococcus aureus pyodermitis at the Department of Dermatology of the Hospital de Clínicas de Uruguay

Larre BA, Querejeta M, Laporte M, Tula N, Agorio C

Language: Spanish
References: 20
Page: 120-124
PDF size: 174.57 Kb.


ABSTRACT

Methicilin-resistant Staphylococcus aureus, a well known inpatient pathogen, is nowadays an important cause of community acquired skin infections. A new genotipicaly and phenotypicaly peculiar clone that caused a sanitary alert was notified community acquired in Uruguay during last years. Herewith we describe the incidence and clinical manifestations of Methicilin-resistant Staphylococcus aureus (MRSA.ca), from the patients that consulted at the Hospital de Clínicas Dermatology Departament during july 1st and september 30, 2004. We included 39 suspicious MRSA.ca patients, 23 of whom had positive bacteriological cultures. Most frequent pathologies that cultured MRSA.ca were eczema, forunulitis/forunulosis and lower limbs wounds.


REFERENCES

  1. Linder C. Infecciones ocasionadas por Staphylococcus aureus meticinino resistente de perfil comunitario: actual desafío epidemiológico. Cap. 2, p. 3-5. En: Staphylococcus aureus meticilin resistente de perfil comunitario: Informe Ateneo general, 2004, Montevideo, Uruguay. Montevideo: OPS; 2004. (OPS/DPC/CD/04).

  2. Dufour P, Gillet Y, Bes M et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002;35:819-24.

  3. Limongi G, Soca A, Medina J et al. Infecciones graves por Staphylococcus aureus meticilino resistente de origen comunitario en medicina intensiva. Centros de Medicina Intensiva de los Hospitales Maciel y Pasteur del Ministerio de Salud Pública. Montevideo, Uruguay, 2004.

  4. Udo EE, Pearmana JW, Grubb WB. Genetic análisis of community isolates of methicillinresistan Staphilococcus aureus in Western Australia. J Hosp Infect 1993;25:97-108.

  5. Hiramatsu K, Okuma K, Ma XX et al. New trends in Staphilococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community. Current Opinion Infect Dis 2002;15:407-13.

  6. Savio Larriera E, Medina J. Consideraciones clínicas y directivas terapéuticas en las enfermedades producidas por SAMR-com. Cátedra de Enfermedades Infecciosas. Dirección General de la Salud Facultad de Medicina Ministerio de Salud Pública Montevideo, Uruguay, 2004.

  7. Giachetto G, Martínez A, Pírez MC et al. Vigi- lancia del uso de antibióticos en el Hospital Pediátrico del Centro Hospitalario Pereira Rossell: susceptibilidad antimicrobiana; gasto y consumo de antibióticos. Rev Med Uruguay 2003;19:208-15.

  8. Okuma K, Iwakawa K, Turnidge JD et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002;40:4289-94.

  9. Adhikari RP, Cook GM, Lamont I et al. Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2002;50:825-31.

  10. Shilesh I, Derek HJ. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retorspective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol 2004;50:854-8.

  11. Cohen PR, Grossman ME. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections. J Am Acad Dermatol 2004;51:132-5.

  12. Sola C, Gribaudo G, Vindel A et al. Identification of a novel methicillin-resistant Staphylococcus aureus epidemic clone in Cordoba, Argentina, involved in nosocomial infections. J Clin Microbiol 2002;40:1427-35.

  13. Aires De Sousa M, Miragaia M, Sanches IS et al. Three-year assessment of methicillinresistant Staphylococcus aureus clones in Latin America from 1996 to 1998. J Clin Microbiol 2001;39:2197-205.

  14. Pedreira W et al. Staphylococcus aureus meticinino resistente de perfil comunitario. Cap. IV p.9-16. En: Staphylococcus aureus meticilino resistente de perfil comunitario: Informe Ateneo general, 2004, Montevideo, Uruguay. Montevideo: OPS; 2004. (OPS/DPC/CD/04).

  15. Baba T, Takeuchi F, Kuroda M et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002;359:1819-27.

  16. Vandenesch F, Naimi T, Enright MC. Community-Acquired Methicillin-Resistant Staphylococcus aureus Carrying Panton-Valentine Leukocidin Genes: Worldwide Emergence. CDC Emerg Infect Dis [serial online] 2003 Vol. 9, No. 8, 2003.

  17. Savio E, Medina J, Hernández O. Emergencia de un nuevo Staphylococcus áureas meticilino-resistente comunitario (SAMRcom) con un perfil más angosto de resistencia. Actualización al 2 de agosto de 2004. Tema del mes. Universidad de la República Facultad de Medicina Cátedra de Enfermedades Infecciosas. Montevideo, Uruguay.

  18. Ma XX, Galiana A, Pedreira W et al. Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay. Emerg Infect Dis 2005;11:973-6. Erratum in: Emerg Infect Dis 2005;11:1329.

  19. Giachetto G, Martínez A, Pírez MC et al. Vigilancia del uso de antibióticos en el Hospital Pediátrico del Centro Hospitalario Pereira Rossell: susceptibilidad antimicrobiana; gasto y consumo de antibióticos. Rev Med Uruguay 2003;19:208-15.

  20. Bazet C. Staphylococcus aureus meticinino resistente de perfil comunitario. Cap. V, pp. 24-34. En: Staphylococcus aureus meticilino resistente de perfil comunitario: Informe Ateneo general, 2004, Montevideo, Uruguay. Montevideo: OPS; 2004. (OPS/DPC/CD/04).




2020     |     www.medigraphic.com